Company needs to let us know time frame in regard to resubmission. Just saw my general practitioner for FOB test. He has heard of RHY and is an investor. He also said that a blood test would be excellent as a half of his clients do not return FOB test. He also has 4 patients with bowel cancer under 40 with 2 under thirty years of age. The incidence is frightening. A blood test can be included in a normal yearly or two -yearly screen. That is why RHY needs to get it right. This is population health screening at its best, reducing burden of disease on the individual, families and communities with a test that is better and easier to administer.
I also IMHO agree with Mr Kohler that this will be successful. Approval was just a pitchfork in the road.
Bill
Company needs to let us know time frame in regard to...
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.8¢ |
Change
-0.002(2.86%) |
Mkt cap ! $16.90M | |||
| Open | High | Low | Value | Volume |
| 7.0¢ | 7.0¢ | 6.8¢ | $47.38K | 683.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 246917 | 6.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 184 | 1 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.8¢ |
Change
-0.002 ( 2.86 %) |
||||
| Open | High | Low | Volume | ||
| 7.0¢ | 7.0¢ | 6.8¢ | 162664 | ||
| Last updated 15.49pm 30/05/2024 ? | |||||
| RHY (ASX) Chart |